These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28506704)

  • 1. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; Stefan C; Budney AJ; George TP
    Schizophr Res; 2018 Apr; 194():47-54. PubMed ID: 28506704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.
    Rabin RA; Kozak K; Zakzanis KK; Remington G; George TP
    Schizophr Res; 2018 Apr; 194():55-61. PubMed ID: 28285022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.
    Rabin RA; Barr MS; Goodman MS; Herman Y; Zakzanis KK; Kish SJ; Kiang M; Remington G; George TP
    Neuropsychopharmacology; 2017 Oct; 42(11):2259-2271. PubMed ID: 28443616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.
    Baker NL; Gray KM; Sherman BJ; Morella K; Sahlem GL; Wagner AM; McRae-Clark AL
    Drug Alcohol Depend; 2018 Jun; 187():270-277. PubMed ID: 29698894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum.
    Bonnet U; Borda T; Scherbaum N; Specka M
    Drug Alcohol Depend; 2015 Oct; 155():302-6. PubMed ID: 26298553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence.
    Rabin RA; Dermody SS; George TP
    Drug Alcohol Depend; 2018 Apr; 185():181-188. PubMed ID: 29459327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
    Lewis J; Molnar A; Allsop D; Copeland J; Fu S
    Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cannabis dependence using escitalopram in combination with cognitive-behavior therapy: a double-blind placebo-controlled study.
    Weinstein AM; Miller H; Bluvstein I; Rapoport E; Schreiber S; Bar-Hamburger R; Bloch M
    Am J Drug Alcohol Abuse; 2014 Jan; 40(1):16-22. PubMed ID: 24359507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.
    Schuster RM; Hanly A; Gilman J; Budney A; Vandrey R; Evins AE
    Drug Alcohol Depend; 2016 Oct; 167():199-206. PubMed ID: 27590742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-taking in schizophrenia and controls with and without cannabis dependence.
    Fischer BA; McMahon RP; Kelly DL; Wehring HJ; Meyer WA; Feldman S; Carpenter WT; Gorelick DA
    Schizophr Res; 2015 Feb; 161(2-3):471-7. PubMed ID: 25467541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use.
    Musshoff F; Madea B
    Ther Drug Monit; 2006 Apr; 28(2):155-63. PubMed ID: 16628124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
    Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
    CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Withdrawal, Mood, and Sleep Inventories After Monitored 3-Week Abstinence in Cannabis-Using Adolescents and Young Adults.
    Sullivan RM; Wallace AL; Stinson EA; Montoto KV; Kaiver CM; Wade NE; Lisdahl KM
    Cannabis Cannabinoid Res; 2022 Oct; 7(5):690-699. PubMed ID: 34678051
    [No Abstract]   [Full Text] [Related]  

  • 16. Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment.
    Yip SW; DeVito EE; Kober H; Worhunsky PD; Carroll KM; Potenza MN
    Drug Alcohol Depend; 2014 Jul; 140():33-41. PubMed ID: 24793365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual cannabis levels in blood, urine and oral fluid following heavy cannabis use.
    Odell MS; Frei MY; Gerostamoulos D; Chu M; Lubman DI
    Forensic Sci Int; 2015 Apr; 249():173-80. PubMed ID: 25698515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craving in patients with schizophrenia and cannabis use disorders.
    Schnell T; Becker T; Thiel MC; Gouzoulis-Mayfrank E
    Can J Psychiatry; 2013 Nov; 58(11):646-9. PubMed ID: 24246436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia-spectrum disorders?
    Yeap ZJS; Marsault J; George TP; Mizrahi R; Rabin RA
    Am J Addict; 2023 Jul; 32(4):367-375. PubMed ID: 36815595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long lasting effects of chronic heavy cannabis abuse.
    Nestoros JN; Vakonaki E; Tzatzarakis MN; Alegakis A; Skondras MD; Tsatsakis AM
    Am J Addict; 2017 Jun; 26(4):335-342. PubMed ID: 28314070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.